Journal & Article

Biochemistry & Molecular Biology

I/F
# Journal I/F

NATURE MEDICINE

People with autism deserve evidence-based policy and care Building a blueprint for intra-tumoral microbial studies Advancing equitable and sustainable urban health Microbial signals in primary and metastatic brain tumors The physiology of dying. Characterizing the physiology of circulatory arrest in humans. Time for the exposome to shape policy. An implantable system to restore hemodynamic stability after spinal cord injury. From one to many gene therapies. Nutrition research must go local Dementia prevention needs clinical trials Reduced-energy diet in women with gestational diabetes: the dietary intervention in gestational diabetes DiGest randomized clinical trial The Future of Medicine. Health AI poses distinct harms and potential benefits for disabled people. How patient advocates influence health policy. The Access to Dialysis in Low- and Middle-Income Countries Commission: lessons for universal health coverage. The Quality Health Information for All Commission: reinventing health communication for the digital era. The expanding repertoire of brain-computer interfaces. Artificial intelligence in drug development. Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. A high-performance brain-computer interface for finger decoding and quadcopter game control in an individual with paralysis. Author Correction: Ferric carboxymaltose for anemia in late pregnancy: a randomized controlled trial. Empagliflozin in nondiabetic individuals with calcium and uric acid kidney stones: a randomized phase 2 trial. Gene therapy targets the retina to treat eye disease. International multicenter validation of AI-driven ultrasound detection of ovarian cancer. Combined endurance and resistance exercise training in heart failure with preserved ejection fraction: a randomized controlled trial. Can quantum computing crack the biggest challenges in health? An evaluation framework for clinical use of large language models in patient interaction tasks. Prioritizing infant mental health: a research-driven pathway for action. Structured programs to train the next generation of clinician scientists. Multi-omic profiling a defined bacterial consortium for treatment of recurrent Clostridioides difficile infection. Genetic insights into global heterogeneity of type 2 diabetes. Large floods drive changes in cause-specific mortality in the United States. Premarital genomic screening in Arab populations of the Middle East. Impact of RSVpreF vaccination on reducing the burden of respiratory syncytial virus in infants and older adults. Medical large language models are vulnerable to data-poisoning attacks. Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trial. T cell malignancies after CAR T cell therapy in the DESCAR-T registry. The TRIPOD-LLM reporting guideline for studies using large language models. Transplantation of a genetically modified porcine heart into a live human. The gut-brain axis underlying hepatic encephalopathy in liver cirrhosis. A generalist medical language model for disease diagnosis assistance. High-efficiency base editing in the retina in primates and human tissues. Green cities for better health. Toward expert-level medical question answering with large language models. Not all KRAS-mutated pancreatic cancers are equal - mutant dosage matters. Effects of early, late and self-selected time-restricted eating on visceral adipose tissue and cardiometabolic health in participants with overweight or obesity: a randomized controlled trial. Neoadjuvant anti-PD-1 alone or in combination with anti-TIGIT or an oncolytic virus in resectable stage IIIB-D melanoma: a phase 1/2 trial. Nationwide real-world implementation of AI for cancer detection in population-based mammography screening. Angiogenic factors versus fetomaternal Doppler for fetal growth restriction at term: an open-label, randomized controlled trial.